Regulation of the permeability transition pore, a voltage-dependent mitochondrial channel inhibited by cyclosporin A.
Mitochondria from a variety of sources possess a regulated inner membrane channel, the permeability transition pore (MTP), which is responsible for the 'permeability transition', a sudden permeability increase to solutes with molecular masses < or = 1500 Da, most easily observed after Ca2+ accumulation. The MTP is a voltage-dependent channel blocked by cyclosporin A with Ki in the nanomolar range. The MTP open probability is regulated by both the membrane potential and matrix pH. The probability of pore opening increases as the membrane is depolarized, while it decreases as matrix pH is decreased below 7.3 through reversible protonation of histidine residues. Many physiological and pathological effectors, including Ca2+ and ADP, modulate MTP operation directly through changes of the gating potential rather than indirectly through changes of the membrane potential (Petronilli, V., Cola, C., Massari, S., Colonna, R. and Bernardi, P. (1993) J. Biol. Chem. 268, 21939-21945). Here we present recent work from our laboratory indicating that (i) the voltage sensor comprises at least two vicinal thiols whose oxidation-reduction state affects the MTP gating potential; as the couple becomes more oxidized the gating potential increases; conversely, as it becomes more reduced the gating potential decreases; (ii) that MTP opening is fully reversible, as mitochondria maintain volume homeostasis through several cycles of pore opening/closure; and (iii) that the mechanism of MTP inhibition by cyclosporin A presumably involves a mitochondrial cyclophilin but does not utilize a calcineurin-dependent pathway.
Petronilli
V
V
C.N.R. Unit for the Study of Physiology of Mitochondria, University of Padova Medical School, Italy.
Nicolli
A
A
Costantini
P
P
Colonna
R
R
Bernardi
P
P
D000591:Amino Acid Isomerases / Q000502:physiology; D000818:Animals; D018053:Arsenites / Q000494:pharmacology; D002118:Calcium; D002352:Carrier Proteins / Q000502:physiology; D016572:Cyclosporine / Q000494:pharmacology*; D004533:Egtazic Acid; D007425:Intracellular Membranes / Q000187:drug effects*; D007473:Ion Channels / Q000187:drug effects; D008564:Membrane Potentials / Q000187:drug effects; D008930:Mitochondria, Liver / Q000187:drug effects* / Q000378:metabolism; D019696:Peptidylprolyl Isomerase; D010539:Permeability / Q000187:drug effects; D051381:Rats; D015398:Signal Transduction
D018053:Arsenites; D002352:Carrier Proteins; D007473:Ion Channels; D004533:Egtazic Acid; D016572:Cyclosporine; D000591:Amino Acid Isomerases; D019696:Peptidylprolyl Isomerase; C015001:arsenite; D002118:Calcium